UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000020601
Receipt No. R000023778
Scientific Title A phase II study of Nivolumab for relapsed/refractory adult T-cell leukemia/lymphoma (ATL)
Date of disclosure of the study information 2016/01/17
Last modified on 2020/01/20 23:04:06

No. Disposal Last modified on Item of update
1 Insert 2016/01/17 11:17:50
2 Update 2016/07/17 09:10:50 Name of primary sponsor
Organization
Organization
Institutions
3 Update 2016/09/05 12:12:54 Institutions
4 Update 2017/10/03 21:41:54 Key inclusion criteria
Key inclusion criteria
5 Update 2017/10/03 21:47:36 Organization
Organization
Last name of contact person
Last name of contact person
Organization
Organization
Organization
Organization
Institute
Organization
Organization
Category of Funding Organization
Organization1
Institutions
6 Update 2019/01/19 14:14:26 Recruitment status
7 Update 2019/07/20 22:30:08 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Division name
Organization
Organization
Address
Address
Tel
Email
Institutions
8 Update 2020/01/20 23:04:06 Recruitment status
Date of IRB
Last follow-up date


Contact us.